BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2021 8:35:47 AM | Browse: 761 | Download: 1986
 |
Received |
|
2020-11-17 00:01 |
|
Peer-Review Started |
|
2020-11-17 00:02 |
|
First Decision by Editorial Office Director |
|
2020-12-28 02:41 |
|
Return for Revision |
|
2020-12-28 02:41 |
|
Revised |
|
2020-12-31 15:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-01-25 08:54 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-01-26 04:05 |
|
Articles in Press |
|
2021-01-26 04:05 |
|
Edit the Manuscript by Language Editor |
|
2021-02-02 01:20 |
|
Typeset the Manuscript |
|
2021-04-12 10:41 |
|
Publish the Manuscript Online |
|
2021-04-29 08:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Case Report |
| Article Title |
Almitrine for COVID-19 critically ill patients – a vascular therapy for a pulmonary vascular disease: Three case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Pierre Huette, Osama Abou Arab, Vincent Jounieaux, Mathieu Guilbart, Mohamed Belhout, Guillaume Haye, Hervé Dupont, Christophe Beyls and Yazine Mahjoub |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Pierre Huette, MD, Doctor, Doctor, Department of Anaesthesia and Critical Care, Amiens Hospital University, Avenue Rene-Laennec, Amiens 80000, France. huette.pierre@chu-amiens.fr |
| Key Words |
COVID-19; Treatment; Acute vascular distress syndrome; Almitrine; Intensive care unit; Safety; Case report |
| Core Tip |
It has been hypothesized that increased pulmonary blood flow associated with impaired hypoxic vasoconstriction may lead to significant intrapulmonary shunt that plays a major role in Coronavirus disease 2019 (COVID-19) related severe hypoxia. In this report, three patients with refractory hypoxemia were treated with continuous infusion of almitrine, a specific pulmonary vasoconstrictor. Almitrine infusion enhanced oxygenation of patients with severe COVID-19 related acute respiratory distress syndrome without any change in pulmonary artery pressures and right ventricular function. |
| Publish Date |
2021-04-29 08:35 |
| Citation |
Huette P, Abou Arab O, Jounieaux V, Guilbart M, Belhout M, Haye G, Dupont H, Beyls C, Mahjoub Y. Almitrine for COVID-19 critically ill patients – a vascular therapy for a pulmonary vascular disease: Three case reports. World J Clin Cases 2021; 9(14): 3385-3393 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i14/3385.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i14.3385 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
